Impact of high-risk features on disease-free survival (DFS) in patients (pts) with high-risk stage II colon cancer (CC) in ACHIEVE-2 trial as part of the IDEA collaboration.

被引：0
|
作者：
Manaka, Dai
Shiozawa, Manabu
Kotaka, Masahito
Gamoh, Makio
Shiomi, Akio
Makiyama, Akitaka
Munemoto, Yoshinori
Rikiyama, Toshiki
Fukunaga, Mutsumi
Ueki, Takashi
Shitara, Kohei
Shinkai, Hiroshi
Tanida, Nobuyuki
Oki, Eiji
Yamazaki, Kentaro
Sunami, Eiji
Yamanaka, Takeharu
Yoshino, Takayuki
Ohtsu, Atsushi
Maehara, Yoshihiko
机构：
[1] Kyoto Katsura Hosp, Kyoto, Japan
[2] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa, Japan
[3] Sano Hosp, Gastrointestinal Canc Ctr, Kobe, Hyogo, Japan
[4] Osaki Citizen Hosp, Dept Med Oncol, Osaki, Japan
[5] Shizuoka Canc Ctr Hosp, Div Colon & Rectal Surg, Shizuoka, Japan
[6] Japan Community Hlth Care Org, Kyushu Hosp, Dept Hematol Oncol, Kitakyushu, Fukuoka, Japan
[7] Fukui Ken Saiseikai Hosp, Fukui, Japan
[8] Jichi Med Univ, Saitama, Japan
[9] Hyogo Prefectural Nishinomiya Hosp, Nishinomiya, Hyogo, Japan
[10] Hamanomachi Hosp, Dept Surg, Fukuoka, Japan
[11] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[12] Chigasaki Municipal Hosp, Dept Surg, Chigasaki, Kanagawa, Japan
[13] Japanese Red Cross Kochi Hosp, Dept Surg, Kochi, Japan
[14] Kyushu Univ, Fukuoka, Japan
[15] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan
[16] Japanese Red Cross Med Ctr, Dept Surg Oncol, Tokyo, Japan
[17] Yokohama City Univ, Sch Med, Dept Biostat, Yokohama, Kanagawa, Japan
[18] Kyushu Cent Hosp, Fukuoka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4011
引用
收藏
页数：2
相关论文
共 50 条
  • [1] THE IMPACT OF PHYSICAL ACTIVITY ON DISEASE-FREE SURVIVAL IN PATIENTS WITH HIGH-RISK STAGE II OR III COLON CANCER: ONE MONTH SCREENING RESULTS
    Goddard, Emma M.
    Dhillon, Haryana M.
    Turner, Jane
    Kabourakis, Michael
    Beale, Philip J.
    Goodwin, Annabel
    Goldstein, David
    Clarke, Stephen J.
    Ouriques, Myra
    Ackland, Stephen P.
    Abell, Fiona
    Bonaventura, Antonio
    Mallesara, G.
    Fischer, Clare
    Kreiger, Laurence
    Lashbrook, Marie
    Vardy, Janette L.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 345 - 345
  • [2] ACHIEVE-2 trial: A randomized phase III trial investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with high-risk stage II colon cancer (CC)
    Yoshino, T.
    Yamanaka, T.
    Shiozawa, M.
    Manaka, D.
    Kotaka, M.
    Gamoh, M.
    Shiomi, A.
    Makiyama, A.
    Munemoto, Y.
    Rikiyama, T.
    Fukunaga, M.
    Ueki, T.
    Shitara, K.
    Shinkai, H.
    Tanida, N.
    Yamazaki, K.
    Sunami, E.
    Ohtsu, A.
    Maehara, Y.
    ANNALS OF ONCOLOGY, 2019, 30
  • [3] Biomarker for high-risk patients with stage II colon cancer
    Watanabe, Toshiaki
    LANCET ONCOLOGY, 2013, 14 (13): : 1247 - 1248
  • [4] IDENTIFICATION OF HIGH-RISK PATIENTS IN STAGE II COLON CANCER
    Lanza, Giovanni
    Gafa, Roberta
    Santini, Alessandra
    Maestri, Iva
    Guerzoni, Laura
    Liboni, Alberto
    Azzena, Gianfranco
    Lelli, Giorgio
    Cavazzini, Luigi
    ANNALS OF ONCOLOGY, 2004, 15 : 66 - 66
  • [5] Long-term effect of peripheral sensory neuropathy (PSN) of 3 or 6 months oxaliplatin-based adjuvant chemotherapy for high-risk stage II colon cancer: ACHIEVE-2 as part of the IDEA collaboration
    Kotaka, M.
    Shiozawa, M.
    Manaka, D.
    Sakamoto, Y.
    Shiomi, A.
    Makiyama, A.
    Munemoto, Y.
    Rikiyama, T.
    Fukunaga, M.
    Ueki, T.
    Shitara, K.
    Shinkai, H.
    Tanida, N.
    Oki, E.
    Yamanaka, T.
    Sunami, E.
    Yamazaki, K.
    Ohtsu, A.
    Maehara, Y.
    Yoshino, T.
    ANNALS OF ONCOLOGY, 2020, 31 : S414 - S414
  • [6] The effect of gaps in chemotherapy on survival in patients with high-risk stage II and stage III colon cancer
    Sada, Yvonne
    Duan, Zhigang
    El-Serag, Hashem
    Davila, Jessica
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34)
  • [7] High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer
    Park, Ji Soo
    Chon, Hong Jae
    Jeung, Hei-Cheul
    Shin, Sang Joon
    Rha, Sun Young
    Ahn, Joong Bae
    Lee, Kang Young
    Kim, Nam Kyu
    Chung, Hyun Cheol
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (09) : 2051 - 2059
  • [8] High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer
    Ji Soo Park
    Hong Jae Chon
    Hei-Cheul Jeung
    Sang Joon Shin
    Sun Young Rha
    Joong Bae Ahn
    Kang Young Lee
    Nam Kyu Kim
    Hyun Cheol Chung
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 2051 - 2059
  • [9] High Disease-Free Survival in Patients with High-Risk MDS Treated with Orca-T
    Gandhi, Arpita
    Hoeg, Rasmus T.
    Patel, Sagar S.
    Waller, Edmund K.
    Pantin, Jeremy M.
    Oliai, Caspian H.
    McClellan, J. Scott
    Pavlova, Anna
    Agodoa, Irene
    Fernhoff, Nathaniel B.
    Meyer, Everett H.
    BLOOD, 2023, 142
  • [10] Adjuvant chemotherapy for stage II colon cancer: the prognostic value of high-risk features
    Cheong, C.
    Suh, K.
    ANNALS OF ONCOLOGY, 2019, 30
12345